INCREASED RISK OF CARDIAC ISCHEMIA AND ARTERIAL THROMBOEMBOLIC EVENTS IN CANCER PATIENTS TREATED WITH BEVACIZUMAB: A META-ANALYSIS

被引：0
|
作者：
Ranpura, Vishal [1 ]
Chuang, Jeff [1 ]
Wu, Shenhong [1 ]
机构：
[1] Stony Brook Univ Hosp, Stony Brook, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2010年 / 55卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1155-276
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysis
    Yazgan, Sati Coskun
    Akkus, Erman
    Yekeduz, Emre
    Urun, Yuksel
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 198
  • [22] Cardiovascular Adverse Events in Patients With Cancer Treated With Bevacizumab: A Meta-Analysis of More Than 20 000 Patients
    Totzeck, Matthias
    Mincu, Raluca Ileana
    Rassaf, Tienush
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (08):
  • [23] Increased Risk of High-Grade Hypertension With Bevacizumab in Cancer Patients: A. Meta-Analysis
    Ranpura, Vishal
    Pulipati, Bhargava
    Chu, David
    Zhu, Xiaolei
    Wu, Shenhong
    AMERICAN JOURNAL OF HYPERTENSION, 2010, 23 (05) : 460 - 468
  • [24] Increased risk of hemorrhage in metastatic colorectal cancer patients treated with bevacizumab: An updated meta-analysis of 12 randomized controlled trials
    Zhu, Xiaoqiang
    Tian, Xianglong
    Yu, Chenyang
    Hong, Jie
    Fang, Jingyuan
    Chen, Haoyan
    MEDICINE, 2016, 95 (34)
  • [25] Incidence and Risk of Hypertension in Cancer Patients Treated With Atezolizumab and Bevacizumab: A Systematic Review and Meta-Analysis
    Jiang, Linhan
    Tan, Xiaoxia
    Li, Jun
    Li, Yaling
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials
    Choueiri, Toni K.
    Schutz, Fabio A. B.
    Je, Youjin
    Rosenberg, Jonathan E.
    Bellmunt, Joaquim
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) : 2280 - 2285
  • [27] Quality of life in ovarian cancer patients treated with bevacizumab: a meta-analysis
    Wu, Di
    He, Jianrong
    Shi, Ping
    Wang, Zirong
    Liu, Min
    Liu, Anchang
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (03) : 269 - 276
  • [28] Hemorrhagic events in cancer patients treated with aflibercept: a meta-analysis
    Peng, Ling
    Bu, Zhibin
    Zhou, Yun
    Ye, Xianghua
    Liu, Junfang
    Zhao, Qiong
    TUMOR BIOLOGY, 2014, 35 (09) : 9419 - 9427
  • [29] Incidence and risk of significantly raised blood pressure in cancer patients treated with bevacizumab: an updated meta-analysis
    Mao Mao An
    Zui Zou
    Hui Shen
    Ping Liu
    Meng Li Chen
    Yong Bing Cao
    Yuan Ying Jiang
    European Journal of Clinical Pharmacology, 2010, 66 : 813 - 821
  • [30] Incidence and risk of significantly raised blood pressure in cancer patients treated with bevacizumab: an updated meta-analysis
    An, Mao Mao
    Zou, Zui
    Shen, Hui
    Liu, Ping
    Chen, Meng Li
    Cao, Yong Bing
    Jiang, Yuan Ying
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (08) : 813 - 821
12345